Sustained release naltrexone effective, safe for opioid users

November 1, 2012
Sustained release naltrexone effective, safe for opioid users
Sustained release technologies for administering the opioid antagonist naltrexone seem to be effective with an acceptable adverse event profile, according to a review published online Oct. 22 in the British Journal of Clinical Pharmacology.

(HealthDay)—Sustained release technologies for administering the opioid antagonist naltrexone (SRX) seem to be effective with an acceptable adverse event profile, according to a review published online Oct. 22 in the British Journal of Clinical Pharmacology.

Nikolaj Kunøe, Ph.D., from the University of Oslo in Norway, and colleagues conducted a qualitative review of the literature to provide an overview of the currently available technologies for SRX and their effectiveness in reducing opioid use.

The researchers found that the most frequently studied SRX formulations have tolerable adverse event profiles and that most studies suggest that SRX is effective at decreasing heroin use. SRX may have a protective effect on mortality and morbidity, based on registry data. In some studies, other outcomes, including concomitant substance use, vocational training attendance, needle use, and risk behavior for blood-borne diseases (including HIV and hepatitis), were also affected by SRX.

"SRX is showing promising, consistent effects in supporting ' efforts to achieve abstinence across different clinical study design and treatment settings," the authors write. "The literature on SRX for opioid addiction still requires more studies in order to confirm initial findings on effects."

One author disclosed a financial tie to Go Medical Industries, which manufactures the Australian implant.

Explore further: Cardiac muscle really knows how to relax: Potential cardio-protective mechanism in heart

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Cardiac muscle really knows how to relax: Potential cardio-protective mechanism in heart

April 19, 2011
New insight into the physiology of cardiac muscle may lead to the development of therapeutic strategies that exploit an inherent protective state of the heart. The research, published by Cell Press online on April 19th in ...

Study sheds light on pain pill abuse

September 26, 2012
A study by a team of University of Kentucky researchers has shed new light on the potential habit-forming properties of the popular pain medication tramadol, in research funded by the National Institute on Drug Abuse. The ...

Polymorphism in opioid gene affects breast cancer survival

March 30, 2012
(HealthDay) -- Genotype at the A118G polymorphism of the µ-opioid receptor gene is associated with breast cancer-specific mortality, according to a study published in the April issue of Anesthesiology.

Recommended for you

Sensor-equipped pill raises technological, ethical questions

November 17, 2017
The first drug with a sensor embedded in a pill that alerts doctors when patients have taken their medications was approved by the Food and Drug Administration, raiding issues involving privacy, cost, and whether patients ...

New painkillers reduce overdose risk

November 16, 2017
Scientists on the Florida campus of The Scripps Research Institute (TSRI) have developed new opioid pain relievers that reduce pain on par with morphine but do not slow or stop breathing—the cause of opiate overdose.

Separating side effects could hold key for safer opioids

November 16, 2017
Opioid pain relievers can be extremely effective in relieving pain, but can carry a high risk of addiction and ultimately overdose when breathing is suppressed and stops. Scientists have discovered a way to separate these ...

US regulators approve first digital pill to track patients

November 14, 2017
U.S. regulators have approved the first drug with a sensor that alerts doctors when the medication has been taken, offering a new way of monitoring patients but also raising privacy concerns.

Introduction is different, but top medications for opioid addiction equally effective

November 14, 2017
With opioid addiction officially declared a public health emergency in the U.S., medical intervention to treat the illness is increasingly important in responding to the epidemic. Now, a new study concludes that two of the ...

Drugstore pain pills as effective as opioids in ER patients

November 7, 2017
Emergency rooms are where many patients are first introduced to powerful opioid painkillers, but what if doctors offered over-the-counter pills instead? A new study tested that approach on patients with broken bones and sprains ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.